More Business Wire
View Older Stories View Newer Stories-
Fortive To Present at 2026 J.P. Morgan Industrials Conference
-
VF Corporation Announces Participation at Citi’s 2026 Global Consumer & Retail Conference
-
CUPE 1698: Lockout Threat Puts Fraser Valley Library Services at Risk
-
AM Best Revises Outlooks to Positive for Members of Plymouth Rock Assurance Group
-
BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) Announces Distribution
-
Lithium Royalty Corp. Announces Receipt of Final Court Approval for Plan of Arrangement with Altius Minerals Corporation
-
Horizon Technology Finance Announces Monthly Distributions for April, May and June 2026 Totaling $0.18 per Share
-
CIBL, Inc. Reports Fourth Quarter and Full Year 2025 Results
-
Valmont to Participate in J.P. Morgan Industrials Conference
-
RYAM Reports Fourth Quarter 2025 Results
-
Horizon Technology Finance Announces Fourth Quarter and Full Year 2025 Financial Results
-
Mayville Engineering Company Announces Fourth Quarter and Full-Year 2025 Results
-
Accel Entertainment Reports Record Fourth Quarter Results Including 7.5% Revenue Increase and Full-Year Revenue of $1.3 Billion
-
Titan America to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 17
-
Primoris Services Corporation to Participate in Investor Conferences
-
Regional Management Corp. and Column N.A. Announce New Lending Partnership to Support Growth and Returns
-
BitGo Holdings to Participate in the Canaccord Genuity 6th Annual Digital Assets Symposium
-
Trane Technologies Completes Acquisition of LiquidStack
-
Brighton Marine, Inc. Announces US Family Health Plan of Southern New England Provider Network Expansion Through Southcoast Health Network Agreement
-
BrightView to Participate in Loop Capital Markets 2026 Virtual Investor Conference
-
Diamond Hill Announces Shareholder Approval of First Eagle Transaction
-
Affirm to host CFO fireside chat on March 17, 2026
-
B&G Foods Reports Financial Results for Fourth Quarter and Full Year 2025
-
CrowdStrike Reports Fourth Quarter and Fiscal Year 2026 Financial Results
-
Ascent Industries Co. Announces Fourth Quarter and Full Year 2025 Results
-
TrueBlue Responds to Misleading Statements From EHS Investments
-
Box Reports Fourth Quarter and Fiscal 2026 Financial Results
-
indie Announces Proposed Convertible Senior Notes Offering
-
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
-
GitLab Reports Fourth Quarter and Full Year Fiscal Year 2026 Financial Results; Board of Directors Authorizes $400 million for Share Repurchase Program
-
Acadia Pharmaceuticals Appoints Jonathan M. Poole to its Board of Directors
-
Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability¹ Beginning in 2026
-
Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results
-
BARK Confirms CEO’s Decision to Withdraw from Great Dane
-
TD SYNNEX to Announce First Quarter Fiscal 2026 Results on March 31, 2026; Announces Updated Reportable Segments
-
TransAct Technologies to Report Fourth Quarter and Full Year 2025 Results On March 10, 2026, Host Conference Call and Webcast
-
Bob’s Discount Furniture Announces Fourth Quarter and Fiscal 2025 Conference Call Date
-
SentinelOne Appoints Sonalee Parekh as Chief Financial Officer
-
Braze To Report Fiscal Fourth Quarter 2026 Results
-
Contineum Therapeutics to Present at the 2026 Leerink Partners Global Healthcare Conference
-
Immunome Reports Full Year 2025 Financial Results and Provides Business Update
-
STAAR Surgical Issues Shareholder Letter
-
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results
-
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress
-
Leonardo DRS CTO Dr. Phil Perconti Named a 2026 Defense News Index Technology Disrupter
-
Intel Board Chair Frank D. Yeary to Retire Following Annual Meeting; Dr. Craig H. Barratt Elected as Chair
-
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Align Technology to Speak at Upcoming Financial Conferences
-
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)
-
Community West Bank Announces Retirement of Chief Operating Officer, Blaine C. Lauhon
